Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer
- 1 February 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (2), 369-376
- https://doi.org/10.1016/0277-5379(89)90032-1
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patientsBritish Journal of Cancer, 1985
- LOW-DOSE AMINOGLUTETHIMIDE IN TREATMENT OF ADVANCED BREAST CANCERThe Lancet, 1984
- EFFECTS OF AMINOGLUTETHIMIDE ON ADRENAL STEROID SECRETIONClinical Endocrinology, 1983
- Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancerBritish Journal of Cancer, 1983
- Stereoselective Inhibition of Aromatase by Enantiomers of Aminoglutethimide*Endocrinology, 1979
- Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*Journal of Clinical Endocrinology & Metabolism, 1978
- Adrenal Suppression with Aminoglutethimide. III. Comparison of Plasma Δ4- and Δ5-Steroids in Postmenopausal Women Treated for Breast Carcinoma*Journal of Clinical Endocrinology & Metabolism, 1978
- Adrenal Suppression with Aminoglutethimide. I. Differential Effects of Aminoglutethimide on Glucocorticoid Metabolism as a Rationale for Use of Hydrocortisone12Journal of Clinical Endocrinology & Metabolism, 1977
- Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancerCancer, 1974
- Preliminary trial of aminoglutethimide in breast cancerCancer, 1973